Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis

Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis

<p>Abstract</p> <p>Background</p> <p>Glucagon-like peptide (GLP-1) analogues are a new class of drugs used in the treatment of type 2 diabetes. They are given by injection, and regulate glucose levels by stimulating glucose-dependent insulin secretion and biosynthesis,...

Full description

Bibliographic Details
Main Authors:	Sharma Pawana, Clar Christine, Royle Pamela L, Shyangdan Deepson S, Waugh Norman R
Format:	Article
Language:	English
Published:	BMC 2010-12-01
Series:	BMC Endocrine Disorders
Online Access:	http://www.biomedcentral.com/1472-6823/10/20

Similar Items

Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis.
by: Christine Clar, et al.
Published: (2009-07-01)

A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
by: Gurung T, et al.
Published: (2015-08-01)

Glucagon-like peptide-1 analogues: An overview
by: Vishal Gupta
Published: (2013-01-01)

Autologous chondrocyte implantation in the knee: systematic review and economic evaluation
by: Hema Mistry, et al.
Published: (2017-02-01)

Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation
by: Pamela Royle, et al.
Published: (2015-07-01)

Treatment with Glucagon-Like Peptide-1 Analogues — a Breakthrough in Diabetes Mellitus Type 2 Therapy
by: V.L. Orlenko, et al.
Published: (2014-05-01)

Investigating the Glucagon Receptor and Glucagon-Like Peptide 1 Receptor Activity of Oxyntomodulin-Like Analogues in Male Wistar Rats
by: Samantha L. Price, MRes, et al.
Published: (2015-12-01)

Possibilities of using analogues of glucagon-like peptide-1 in various disease entities
by: Weronika Bielka, et al.
Published: (2021-02-01)

Glucagon-Like Peptide-1
by: Joel P. Giblett, BM, BSc, et al.
Published: (2016-06-01)

Efficacy and safety of dulaglutide: a novel once-weekly glucagon-like peptide-1 analogue
by: A. S. Pogorelova, et al.
Published: (2018-03-01)

Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality?
by: Maryna V Basalay, et al.
Published: (2020-01-01)

Glucagon-Like Peptide-2 Analogue ZP1849 Augments Colonic Anastomotic Wound Healing
by: Marie Kjaer, et al.
Published: (2020-01-01)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
by: Seungah Lee, et al.
Published: (2017-03-01)

The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice.
by: Emil Egecioglu, et al.
Published: (2013-01-01)

Glucagon-like peptide-1 and glucagon-like peptide-1 analogs nanotechnology-based systems for prevention and therapy of diabetes
by: Ana Francisca Lopes Correia de Araújo
Published: (2019)

Amino-terminally modified analogues of glucagon-like peptide-1 (7-36) amide : activity and antidiabetic potential
by: Green, Brian Desmond
Published: (2003)

Glucagon-like peptide 1 (GLP-1)
by: T.D. Müller, et al.
Published: (2019-12-01)

Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus
by: Olusola F. Onoviran, et al.
Published: (2019-07-01)

Renal effects of glucagon-like peptide receptor agonists in patients with type 1 diabetes mellitus
by: O K Vikulova, et al.
Published: (2018-06-01)

The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
by: Marina Vladimirovna Shestakova
Published: (2010-09-01)

How glucagon-like peptide 1 receptor agonists work
by: Christine Rode Andreasen, et al.
Published: (2021-07-01)

Exendin-4, a glucagon-like peptide-1 analogue accelerates healing of chronic gastric ulcer in diabetic rats.
by: Yen-Cheng Chen, et al.
Published: (2017-01-01)

Glucagon-like peptide-1 analogue, liraglutide, delays onset and reduces severity of experimental autoimmune encephalitis in Lewis rats
by: Brian DellaValle, et al.
Published: (2016-11-01)

The genetic signature of diabetes mellitus-from glucagon-like peptide-1 (GLP-1) treatment to diagnosis
by: Chia Hung Lin, et al.
Published: (2016)

Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus
by: Kira B. Harris, et al.
Published: (2015-02-01)

Clinical Application of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus
by: Young Min Cho, et al.
Published: (2013-12-01)

Design of Glucagon-Like Peptide-1 Receptor Agonist for Diabetes Mellitus from Traditional Chinese Medicine
by: Hsin-Chieh Tang, et al.
Published: (2014-01-01)

Heart and mind: The story of glucagon-like peptide-1 receptor agonists in type 2 diabetes mellitus
by: Djordje S Popovic
Published: (2020-01-01)

A simplified search strategy for identifying randomised controlled trials for systematic reviews of health care interventions: a comparison with more exhaustive strategies
by: Waugh Norman, et al.
Published: (2005-07-01)

Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
by: Silvano Paternoster, et al.
Published: (2018-10-01)

The Role of the Glucagon-like Peptide-1 Receptor in Atherosclerosis
by: Panjwani, Naim
Published: (2012)

The Role of the Glucagon-like Peptide-1 Receptor in Atherosclerosis
by: Panjwani, Naim
Published: (2012)

Equine glucagon-like peptide-1 receptor physiology
by: Murad H. Kheder, et al.
Published: (2018-01-01)

Signalling and regulation of the glucagon-like peptide-1 receptor
by: Lu, Jing
Published: (2014)

Exendin-4, a glucagon-like peptide-1 analogue, improves Listeria monocytogenes infection in diabetic db/db mice
by: Hsien-Yueh Liu, et al.
Published: (2015)

Synthesis of a possible glucagon inhibitor by semisynthesis of a glucagon analogue of [HARG¹²]-glucagon and [DES-HIS¹][HARG¹²]-glucagon
by: Lo, Suzanne Sin-Mui
Published: (1980)

Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research
by: Levin PA, et al.
Published: (2017-04-01)

Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects
by: Takaaki Murakami, et al.
Published: (2020-11-01)

Systematic reviews of epidemiology in diabetes: finding the evidence
by: Waugh Norman, et al.
Published: (2005-01-01)

Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation
by: N Waugh, et al.
Published: (2013-11-01)

Cannot write session to /tmp/vufind_sessions/sess_krjq37k76cfrfoh4q4eu4nqkpe